Abstract
Introduction: anemia is the most common nutritional disorder in the world, and because during pregnancy there is a great demand for iron, constitutes a signifcant risk of developing iron defciency anemia. Anemia is the most commonly diagnosed blood disorder during pregnancy, so that all pregnant women are at risk for anemia in pregnancy, being more frequent in developing countries. It is referred to as a secondary dilutional process to increase in plasma volume that occurs during pregnancy. Clinical studies showed that anemia in pregnancy is associated with complications in the mother, fetus and newborn, relating to increased fetal and perinatal morbidity and mortality, hence the importance of proper prenatal supplementation with iron needed to provide increasing demands on this woman. Objective: understand the pathophysiology and establish the criteria for diagnosis and treatment of any complications of anemia in pregnant women, and there is evidence of the importance of their treatment during the prenatal control. Methodology: a literature search in the electronic databases PubMed, Ovid, Elsevier, Interscience, EBSCO, Scopus, SciELO was performed. Results: case series or descriptive reviewed, all that showed a statistically signifcant number of patients. Conclusions: anemia in pregnancy is a common syndrome that with proper prenatal care can be prevented, diagnosed and treated before complications show. It is necessary to increase the coverage of prenatal care for all pregnant, and is mandatory for health professionals to make appropriate control and optimal prescription of prophylactic iron in this population group. (MÉD.UIS. 2013;26(3):45-50)
References
2. Camaschella C, Poggiali E. Inherited disorders of iron metabolism.Current Opinion in Pediatrics.2011;23(1):14-20.
3. Tierney L, McPhe S, Papadakis M. Diagnóstico clinic y tratamiento. México: Editorial El Manual Moderno;2002. p. 781-2.
4. Mc Free J. Anemia in pregnancy.Obstetric GynecolSurv.1973;28:769-78.
5. Lee A, Okam MM. Anemia in pregnancy.Hematol Oncol Clin North Am.2011;25(2):241–59.
6. Carrera J, Mallafré J, Serra B. Protocolos de obstetricia y medicina perinatal del Instituto Universitario Dexeus. 1st Ed. Barcelona: Masson; 1998.
7. Gabbe S, Niebyl J, Simpson J, Landon M, Galan H, Jauniaux E, et al. Obstetrics: Normal and problem pregnancies. 5th ed. Philadelphia: Elsevier; 2007.
8. Anderson A, Lichorad A. Hypertensive disorders, diabetes mellitus, and anemia three common medical complications of pregnancy.Primary care: clinics in office practice.2000;27(1):185-201.
9. Bergmann R, Richter R, Bergmann K, Dudenhausen J. Prevalence and risk factors for early postpartum anemia.Eur J Obste Gynecol Reprod Biol.2010;150(2):126-31.
10. World Health organization. Iron deficiency anaemia. Assessment, prevention and control.2001. WHO/NHD/01.3.
11. Tarin L, Gómez D, Jaime J. Anemia en el embarazo. Estudio de 300 mujeres con embarazo a término.Med Univer.2003;5(20):149-53.
12. Zaki M. Parvovirus and herpes simplex association with unexplained anemia in pregnancy: a prospective study.Hematology.2008;13(5):303-6.
13. Pasricha S, Flecknoe-Brown S, Allen K, Gibson P, McMahon L, Olynyk J, et al. Diagnosis and management of iron deficiency anaemia: a clinical update.Med J Aust.2010;193(9):525-32.
14. Andrews N. Disorders of Iron metabolism.N Engl J Med.1999;341:1986-95.
15. Kaplinsky C. Parenteral Iron Therapy.IMAJ.2008;10:372-3.
16. Asma S, Boga C, Ozdogu H. Safety, therapeutic effectiveness, and cost of parenteral iron therapy.Int J Hematol.2009;90(1):24-7.
17. http://www.clausen.com.uy/admin/Prospectos/ferroin.pdf
18. http://products.sanofi-aventis.ca/en/ferrlecit.pdf
19. http://www.plmfarmacias.com/colombia/DEF/PLM/productos/27695.htm
20. Milman N. Prepartum anaemia: prevention and treatment.Ann Hematol.2008;87(12):949-59.
21. Frewin R et al. ABC of clinical haematology: iron deficiency anaemia. BMJ 1997; 314:360-366.
22. Milman N. Iron and pregnancy–a delicate balance.Ann Hematol.2006;85(9):559-65
23. Ravell EG. Detección por laboratorio de la deficiencia de hierro en un grupo de mujeres gestantes de nivel socioeconómico bajo en la ciudad de Mérida, Yucatán. México: Universidad Autónoma de Yucatán; 1990.
24. http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022180lbl.pdf25. Protocolo de Vigilancia Epidemiológica para Malaria. Actualizado por Luis Armando Galeano Marín, médico especialista, el 31 de julio de 2009. Direccion Seccional De Salud Y Protección Social De Antioquia.
26. Pels S, Paidas M. Microangiopathic disorders in pregnancy.Hematol Oncol Clin North Am.2011;25(2):311-22.
27. Steer P. Maternal hemoglobin concentration and birth weight.Am J Clin Nutr.2000;71(5 Suppl):1285-7.
28. Klebanoff M, Shiono P, Selby J, Trachtenberg A, Graubard B. Anemia and spontaneous preterm birth.Am J Obstet Gynecol.1991;164(1 Pt 1):59-63.
29. Guindi, E., et al. Severe maternal anemia and pregnancy outcome. Gynecology and Obstetrics. Paris. 2004. Vol. 10. 506-509.
30. Lingxia, Z., et. all, Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial. BMJ. 2008. Vol 337. Nº 2001, p. 1-11.
31. SIfakis A, Pharmakides G. Anemia in pregnancy. Annals of the New York Academy of Sciences 2000; 900:125-136.
32. Lopez, MJ. Sanchez, JI. Sanchez, MC. Caldera, M, Suplementos en embarazadas: controversias, evidencias y recomendaciones. Sistema Nacional de Salud. Vol 34, n 4/2010.